Lipopolysaccharide로 유도된 RAW 264.7 대식세포와 Dextran Sulfate Sodium 유도 급성 대장염 마우스에 대한 콩배나무 추출물의 항염증 효과
Anti-inflammatory Effect of Pyrus calleryana var. fauriei on Dextran Sulfate Sodium-induced Acute Colitis in Mice and Lipopolysaccharide-treated RAW 264.7 cells
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Back ground: Inflammatory bowel disease (IBD) is a pathological condition of the gastrointesti- nal tract characterized by chronic and relapsing inflammation. This study investigated the anti- inflammatory effects of Pyrus calleryana var. fauriei extract (PCE) in vitro and in vivo. Methods and Results: Lipopolysaccharide (LPS)-treated RAW 264.7 cells and dextran sulfate sodium (DSS)-induced colitis mice were used to evaluate the effects of PCE. In RAW 264.7 cells, PCE inhibited nitric oxide production and phagocytosis without cytotoxicity, and the production of the pro-inflammatory cytokines tumor necrosis factor-α and interleukin (IL)-6. Colitis was induced in the mice using 2% DSS for 5 days, and PCE was administered for 14 days. PCE treatment relieved the symptoms of colitis, such as weight loss, diarrhea, and bloody feces. Moreover, PCE ameliorated splenomegaly and colonic shortening, indicators of colitis. PCE reduced the levels of inflammatory cytokines, IL-6 and IL-22. Histological analysis revealed that PCE treatment allevi- ated colonic mucosal damage and macrophage infiltration. Conclusions: These results suggest that PCE has anti-inflammatory activity on LPS-treated RAW 264.7 cells, and ameliorates the clinical symptoms and colonic mucosal damage of DSS-induced colitis in mice. Therefore, PCE is a potential therapeutic candidate for the treatment of IBD
Abstract
Back ground: Inflammatory bowel disease (IBD) is a pathological condition of the gastrointesti- nal tract characterized by chronic and relapsing inflammation. This study investigated the anti- inflammatory effects of Pyrus calleryana var. fauriei extract (PCE) in vitro and in vivo. Methods and Results: Lipopolysaccharide (LPS)-treated RAW 264.7 cells and dextran sulfate sodium (DSS)-induced colitis mice were used to evaluate the effects of PCE. In RAW 264.7 cells, PCE inhibited nitric oxide production and phagocytosis without cytotoxicity, and the production of the pro-inflammatory cytokines tumor necrosis factor-α and interleukin (IL)-6. Colitis was induced in the mice using 2% DSS for 5 days, and PCE was administered for 14 days. PCE treatment relieved the symptoms of colitis, such as weight loss, diarrhea, and bloody feces. Moreover, PCE ameliorated splenomegaly and colonic shortening, indicators of colitis. PCE reduced the levels of inflammatory cytokines, IL-6 and IL-22. Histological analysis revealed that PCE treatment allevi- ated colonic mucosal damage and macrophage infiltration. Conclusions: These results suggest that PCE has anti-inflammatory activity on LPS-treated RAW 264.7 cells, and ameliorates the clinical symptoms and colonic mucosal damage of DSS-induced colitis in mice. Therefore, PCE is a potential therapeutic candidate for the treatment of IBD
참고문헌 (39)
- Agrawal M, "JAK inhibitors safety in ulcerative colitis : Practical implications", Journal of Crohn’s and Colitis, 14, pp.S755~S760 (2020)
- Ananthakrishnan AN, "Changing global epidemiology of inflammatory bowel diseases : Sustaining health care delivery into the 21st century", Clinical Gastroenterology and Hepatology, 18, pp.1252~1260 (2020)
- Bain CC, "Macrophages in intestinal home-ostasis and inflammation", Immunological Reviews, 260, pp.102~117 (2014)
- Baumgart DC, "Inflammatory bowel disease : Clinical aspects and established and evolving therapies", Lancet, 369, pp.1641~1657 (2007)
- Berberat PO, "Heme oxygenase-1-generated biliverdin ameliorates experimental murine colitis", Inflammatory Bowel Disease, 11, pp.350~359 (2005)
- Cai Z, "Treatment of inflammatory bowel disease: A comprehensive review", Frontiers in Medicine, 8, pp.765474~ (2021)
- Chassaing B, "Dextran sulfate sodium(DSS)-induced colitis in mice", Current Protocols in Immunology, 104, pp.15~25 (2015)
- Chen B, "Dietary tangeretin alleviated dextran sulfate sodium-induced colitis in mice via inhibiting inflammatory response, restoring intestinal barrier function, and modulating gut microbiota", Journal of Agricultural and Food Chemistry, 69, pp.7663~7674 (2021)
- Chen Y, "Oral chondrotin sulfate functionalized natural polyphenol for targeted therapy of ulcerative colitis", Material and Design, 238, pp.112645~ (2024)
- Cho KH, "Pyrus ussuriensis Maxim. leaves extract ameliorates DNCB-induced atopic dermatitis-like NC", Nga mice, 2018, pp.48, 76~83
- Duan L, "Natural anti-inflammatory compounds as drug candidates for inflammatory bowel disease", Frontiers in Pharmacology, 12, pp.684486~ (2021)
- Duque GA, "Macrophage cytokines : Involvement in immunity and infectious disease", Frontiers in Immunology, 5, pp.491~ (2014)
- Erben U, "A guide to histomorphological evaluation of intestinal inflammation in mouse models", International Journal of Clinical and Experimental Pathology, 7, pp.4557~4576 (2014)
- Fujiwara N, "Macrophages in inflammation", Current Drug Targets-Inflammation and Allergy, 4, pp.281~286 (2005)
- Gajendran M, "A comprehensive review and update on ulcerative colitis", Disease-a-Month, 65, pp.100851~ (2019)
- Grosso G, "Dietary polyphenols are inversely associated with metabolic syndrome in Polish adults of the HAPIEE study", European Journal of Nutrition, 56, pp.1409~1420 (2017)
- Han U, "Protective effects of patchouli alcoholic against DSS-induced ulcerative colitis", Scientific Reports, 14, pp.16745~ (2024)
- Hirayama D, "The phagocytic function of macrophage-enforcing innate immunity and tissue homeostasis", International Journal of Molecular Science, 19, pp.92~ (2017)
- Joo YE, "Natural product-derived drugs for the treatment of inflammatory bowel diseases", Intestinal Research, 12, pp.103~109 (2014)
- Kaplan GG, "The four epidemiological stages in the global evolution of inflammatory bowel disease", Nature Reviews Gastroenterology and Hepatology, 18, pp.56~66 (2021)
- Lamkanfi M, "Inflammasomes and their roles in health and disease", Annual Review of Cell and Developmental Biology, 28, pp.137~161 (2012)
- Lavelle A, "Gut microbiota-derived metabolites as key actors in inflammatory bowel disease", Nature Reviews Gastroenterology and Hepatology, 17, pp.223~237 (2020)
- Leppkes M, "Cytokines in inflammatory bowel diseases-Update 2020", Pharmacological Research, 158, pp.104835~ (2020)
- Marafini I, "Inflammatory cytokines : From discoveries to therapies in IBD", Expert Opinion Biological Therapy, 19, pp.1207~1217 (2019)
- Michielan A, "Intestinal permeability in inflammatory bowel disease : Pathogenesis, clinical evaluation, and therapy of leaky gut", Mediator Inflammation, 2015, pp.628157~ (2015)
- Nishi K, "Anti-inflammatory activity of the combination of nobiletin and docosahexaenoic acid in lipopolysaccharide-stimulated RAW 264. 7 cells : A potential synergistic anti-inflammatory effect", Nutrients, 16, pp.2080~ (2024)
- Oz HS, "Green tea polyphenols and sulfasalazine have parallel anti-inflammatory properties in colitis models", Frontiers in Immunology, 4, pp.132~ (2013)
- Piodi LP, "Managing osteoporosis in ulcerative colitis : Something new?", World Journal of Gastroenterology, 20, pp.14087~14098 (2014)
- Rienks J, "Polyphenol exposure and risk of type 2 diabetes : dose-response meta-analyses and systematic review of prospective cohort studies", American Journal of Clininical Nutrition, 108, pp.49~61 (2018)
- Romier B, "Dietary polyphenols can modulate the intestinal inflammatory response", Nutrition Reviews, 67, pp.363~378 (2009)
- Singh S, "Exploring the therapeutic potential and bioactive compounds in Pyrus species", Pharmacological Research-Modern Chinese Medicine, 10, pp.100342~ (2024)
- Sozzani S, "Chronic inflammatory diseases : Do immunological patterns drive the choice of biotechnology drugs? A critical review", Autoimmunity, 47, pp.287~306 (2014)
- Tian M, "Chemical constitutes, antibacterial and anti-inflammatory properties of Pyrus calleryana Dcne. essential oil", Industrial Crops and Products, 2024, pp.117353~ (2024)
- Taciak B, "Evaluation of phenotypic and functional stability of RAW 264.7 cell line through serial passages", PLoS One, 13, pp.e0198943~ (2018)
- Vezza T, "Flavonoids in inflammatory bowel disease : A review", Nutrients, 8, pp.211~ (2016)
- Wirtz S, "Chemically induced mouse models of intestinal inflammation", Nature Protocols, 2, pp.541~546 (2007)
- Yu LZ, "Expression of interleukin-22", STAT3 signaling pathway in ulcerative colitis and related carcinogenesis, 2013, pp.19, 2638~2649
- Zhang YZ, "Inflammatory bowel disease : Pathogenesis", World Journal of Gastroenterology, 20, pp.91~99 (2014)
- Zhu L, "Cellular metabolism and macrophage functional polarization", International Reviews of Immunology, 34, pp.82~100 (2015)